资讯

National Institute for Health and Care Excellence12 小时
In development: Guidance, quality standards and advice
Abemaciclib with fulvestrant for previously treated hormone receptor-positive HER2-negative advanced breast cancer TSID 12065 Technology appraisal guidance TBC Abicipar pegol for treating wet ...